| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medicine and Physiology University of Toronto
(X.H., M.B.W., Y.-h.K., L.S., H.Y.G.) and The Toronto Hospital
(H.Y.G., M.B.W.) Toronto, Ontario, Canada M5S 1A8
Divisions of Respirology (G.L.) and Cell Biology (W.S.T.)
Hospital for Sick Children Research Institute Toronto, Ontario,
Canada M5G 1X8
We and others have previously shown that insulin-secreting cells of the pancreas express high levels of SNAP-25 (synaptosomal-associated protein of 25 kDa), a 206-amino acid t-SNARE (target soluble N-ethylmaleimide-sensitive factor attachment protein receptors) implicated in synaptic vesicle exocytosis. In the present study, we show that SNAP-25 is required for insulin secretion by transient transfection of Botulinum Neurotoxin A (BoNT/A) into insulin-secreting HIT-T15 cells. Transient expression of BoNT/A cleaved the endogenous as well as overexpressed SNAP-25 proteins and caused significant reductions in K+ and glucose-evoked secretion of insulin. To determine whether the inhibition of release was due to the depletion of functional SNAP-25 or the accumulation of proteolytic by-products, we transfected cells with SNAP-25 proteins from which the C-terminal nine amino acids had been deleted to mimic the effects of the toxin. This modified SNAP-25 (amino acids 1197) remained bound to the plasma membrane but was as effective as the toxin at inhibiting insulin secretion. Microfluorimetry revealed that the inhibition of secretion was due neither to changes in basal cytosolic Ca2+ levels nor in Ca2+ influx evoked by K+-mediated plasma membrane depolarization. Electron microscopy revealed that cells transfected with either BoNT/A or truncated SNAP-25 contained significantly higher numbers of insulin granules, many of which clustered close to the plasma membrane. Together, these results demonstrate that functional SNAP-25 proteins are required for insulin secretion and suggest that the inhibitory action of BoNT/A toxin on insulin secretion is in part caused by the production of the plasma membrane-bound cleavage product, which itself interferes with insulin granule docking and fusion.
This article has been cited by other articles:
![]() |
J. Vikman, H. Svensson, Y.-C. Huang, Y. Kang, S. A. Andersson, H. Y. Gaisano, and L. Eliasson Truncation of SNAP-25 reduces the stimulatory action of cAMP on rapid exocytosis in insulin-secreting cells Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E452 - E461. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Leung, E. P. Kwan, B. Ng, Y. Kang, and H. Y. Gaisano SNAREing Voltage-Gated K+ and ATP-Sensitive K+ Channels: Tuning {beta}-Cell Excitability with Syntaxin-1A and Other Exocytotic Proteins Endocr. Rev., October 1, 2007; 28(6): 653 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Hsieh, K.-H. Liang, Y.-J. Hung, L.-C. Huang, D. Pei, Y.-T. Liao, S.-W. Kuo, M. S.-J. Bey, J.-L. Chen, and E. Y. Chen Analysis of epistasis for diabetic nephropathy among type 2 diabetic patients Hum. Mol. Genet., September 15, 2006; 15(18): 2701 - 2708. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sheu, E. A. Pasyk, J. Ji, X. Huang, X. Gao, F. Varoqueaux, N. Brose, and H. Y. Gaisano Regulation of Insulin Exocytosis by Munc13-1 J. Biol. Chem., July 18, 2003; 278(30): 27556 - 27563. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Foran, N. Mohammed, G. O. Lisk, S. Nagwaney, G. W. Lawrence, E. Johnson, L. Smith, K. R. Aoki, and J. O. Dolly Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type A. BASIS FOR DISTINCT DURATIONS OF INHIBITION OF EXOCYTOSIS IN CENTRAL NEURONS J. Biol. Chem., January 3, 2003; 278(2): 1363 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Gaisano, C.-G. Ostenson, L. Sheu, M. B. Wheeler, and S. Efendic Abnormal Expression of Pancreatic Islet Exocytotic Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptors in Goto-Kakizaki Rats Is Partially Restored by Phlorizin Treatment and Accentuated by High Glucose Treatment Endocrinology, November 1, 2002; 143(11): 4218 - 4226. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. MacDonald, G. Wang, S. Tsuk, C. Dodo, Y. Kang, L. Tang, M. B. Wheeler, M. S. Cattral, J. R. T. Lakey, A. M. F. Salapatek, et al. Synaptosome-Associated Protein of 25 Kilodaltons Modulates Kv2.1 Voltage-Dependent K+ Channels in Neuroendocrine Islet {beta}-Cells through an Interaction with the Channel N Terminus Mol. Endocrinol., November 1, 2002; 16(11): 2452 - 2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ji, S. Tsuk, A. M. F. Salapatek, X. Huang, D. Chikvashvili, E. A. Pasyk, Y. Kang, L. Sheu, R. Tsushima, N. Diamant, et al. The 25-kDa Synaptosome-associated Protein (SNAP-25) Binds and Inhibits Delayed Rectifier Potassium Channels in Secretory Cells J. Biol. Chem., May 31, 2002; 277(23): 20195 - 20204. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, Y.-H. Kang, E. A. Pasyk, L. Sheu, M. B. Wheeler, W. S. Trimble, A. Salapatek, and H. Y. Gaisano Ca2+ influx and cAMP elevation overcame botulinum toxin A but not tetanus toxin inhibition of insulin exocytosis Am J Physiol Cell Physiol, September 1, 2001; 281(3): C740 - C750. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. MacDonald, X. F. Ha, J. Wang, S. R. Smukler, A. M. Sun, H. Y. Gaisano, A. M. F. Salapatek, P. H. Backx, and M. B. Wheeler Members of the Kv1 and Kv2 Voltage-Dependent K+ Channel Families Regulate Insulin Secretion Mol. Endocrinol., August 1, 2001; 15(8): 1423 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Ward, J. Pevsner, M. A. Scullion, M. Vaughn, and J. Kaplan Syntaxin 7 and VAMP-7 are Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptors Required for Late Endosome-Lysosome and Homotypic Lysosome Fusion in Alveolar Macrophages Mol. Biol. Cell, July 1, 2000; 11(7): 2327 - 2333. [Abstract] [Full Text] |
||||
![]() |
J. E. Keller and E. A. Neale The Role of the Synaptic Protein SNAP-25 in the Potency of Botulinum Neurotoxin Type A J. Biol. Chem., April 13, 2001; 276(16): 13476 - 13482. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |